95019-16-2

Basic information

• Product Name: 4-Methyl-1,2,3,6-tetrahydropyridine hydrochloride
• Synonyms: 4-Methyl-1,2,3,6-tetrahydropyridine hydrochloride;Efinaconazole Impurity 1;4-METHYL-1,2,3,6-TETRAHYDROPYRIDINE HCL
• CAS NO: 95019-16-2
• Molecular Formula: C6H12ClN
• Molecular Weight: 133.61918
• Mol File: 95019-16-2.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-Methyl-1,2,3,6-tetrahydropyridine hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Methyl-1,2,3,6-tetrahydropyridine hydrochloride(95019-16-2)
• EPA Substance Registry System: 4-Methyl-1,2,3,6-tetrahydropyridine hydrochloride(95019-16-2)

Safety Data

• Hazardous Substances Data: 95019-16-2(Hazardous Substances Data)

Usage

General Description

4-Methyl-1,2,3,6-tetrahydropyridine hydrochloride is a chemical compound with the molecular formula C6H13N?HCl. It is commonly used in laboratory settings as a neurotoxin to induce Parkinson's disease-like symptoms in animal models. 4-Methyl-1,2,3,6-tetrahydropyridine hydrochloride is known to selectively destroy dopaminergic neurons in the brain, leading to motor deficits and other symptoms characteristic of Parkinson's disease. Research on this compound has provided valuable insights into the neuropathology and potential treatment strategies for Parkinson's disease. Additionally, it has been used to study the mechanisms of neurodegeneration and to test potential therapeutic agents for this debilitating neurodegenerative disorder.

Upstream product

• 50-00-0 formaldehyd 
• 78-79-5 isoprene 
• 57042-58-7 1-benzyl-1-bromo-4-methylpyridinium bromide 
• 108-89-4 picoline 
• 112423-96-8 N-<(R)-2-Hydroxy-1-methoxycarbonylethyl>-4-methyl-3,4-didehydropiperidin 
• 32018-56-7 1-benzyl-4-methyl-1 ,2,3,6-tetrahydropyridine 

Relevant articles and documents

Ytterbium(III) trifluoromethanesulfonate catalyzed solid phase aza Diels-Alder reaction and subsequent facile adduct release

Ytterbium(III) trifluoromethanesulfonate has been demonstrated to catalyze the solid phase aza Diels-Alder reaction of an aldehyde, a diene, and immobilized benzylamine. The [4+2] adducts were cleaved from solid support efficiently using a 'trace-less' re

2-SULFONYLAMINO-4-HETEROARYL BUTYRAMIDE ANTAGONISTS OF CCR10

This invention relates to a compound of formula (I) and the pharmaceutically acceptable salts thereof wherein R1, R2, R4. Ar and Het are as defined herein. The invention also relates to methods of using the compound of for

Aminosaeuremethylester als chirale Auxiliare in Aza-Diels-Alder-Reaktionen in waessriger Loesung

-